| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.03B | 15.26B | 14.12B | 12.35B | 10.73B | 9.52B |
| Gross Profit | 8.26B | 8.28B | 7.08B | 5.83B | 4.12B | 3.66B |
| EBITDA | 5.81B | 5.44B | 5.36B | 3.76B | 3.30B | 2.50B |
| Net Income | 2.54B | 2.54B | 2.83B | 2.29B | 1.89B | 1.49B |
Balance Sheet | ||||||
| Total Assets | 41.42B | 42.03B | 33.53B | 25.13B | 18.42B | 11.76B |
| Cash, Cash Equivalents and Short-Term Investments | 3.81B | 3.92B | 4.23B | 6.88B | 5.78B | 3.63B |
| Total Debt | 10.41B | 10.07B | 5.22B | 3.86B | 3.05B | 1.96B |
| Total Liabilities | 21.24B | 21.05B | 18.34B | 13.26B | 9.28B | 5.01B |
| Stockholders Equity | 14.05B | 15.53B | 11.57B | 9.62B | 7.50B | 5.52B |
Cash Flow | ||||||
| Free Cash Flow | 6.50M | -551.00M | -5.20B | -2.69B | 1.05B | -176.74M |
| Operating Cash Flow | 145.50M | 704.00M | -574.00M | 2.64B | 3.58B | 1.64B |
| Investing Cash Flow | -174.00M | -2.54B | -4.74B | -5.51B | -2.66B | -1.89B |
| Financing Cash Flow | 61.50M | 1.38B | 2.31B | 3.58B | 1.07B | 1.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥18.26B | 13.52 | ― | 3.53% | 5.03% | -9.55% | |
75 Outperform | ¥9.42B | 12.83 | ― | 3.85% | 1.75% | 24.87% | |
66 Neutral | ¥21.52B | 23.11 | ― | ― | 30.15% | 31.28% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥464.99B | 19.63 | 15.67% | 1.31% | 12.48% | 18.38% | |
59 Neutral | ¥40.08B | 8.81 | ― | 1.28% | -7.46% | 11.57% | |
59 Neutral | ¥14.63B | 37.44 | ― | 1.01% | 17.19% | -43.91% |